Zika vaccine research continues in the absence of a large-scale outbreak, but a shortage of cases is making it hard to test for efficacy.
Merck is already in phase 3 testing for its next-generation pneumococcal vaccine, and Pfizer's CFO said his company is "all in" on advancing its…
Here is some other vaccine news of note for the week.
Without additional funding, the world won't see new "highly efficacious" vaccines against HIV, tuberculosis and malaria, according to a new…
No production or safety problems were found at the other 45 vaccine manufacturers in China, the country's drug regulator says.
Aiming to redeploy its efforts toward new drug launches, GSK will cut 450 sales jobs, and 100 each at HQ and its commercial hub in North Carolina.
Sun brings experience from the FDA, CDC and Walter Reed Army Institute of Research to his role at the biotech unicorn.
A group of pediatric experts has recommended injected vaccines over AstraZeneca's FluMist for the upcoming season.
In what a WHO official described as "high community demand," 4,625 doses of Merck's Ebola vaccine, rVSV-ZEBOV, have been given in the latest…
